News list for "恶性"

CureX宣布开始使用业务收入回购并销毁CUX代币

1月23日消息,CureX近日宣布,将其TRC-T治疗恶性滑膜肉瘤的产品20%销售额用于回购CUX并进行销毁。此次操作标志着CureX在推动其生物技术产品应用的同时,进一步加强了CUX代币的价值和市场稳定性。在首轮回购中,CureX购买了100个SOL,并销毁了4259993枚CUX代币。CureX承诺,未来将持续利用其产品收入的一部分回购并销毁CUX代币。CureX将继续...

clock
2025-01-23 10:16:50
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.